Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond

Purpose: Radiotherapy is integral in the management of hematological malignancies (HM). Standard radiotherapy dose fractionation regimens range between 20 and 50 Gy in 10–25 fractions over 2–5 weeks. This study presents the outcomes of patients with HM treated with hypofractionation radiotherapy (HF...

Полное описание

Библиографические подробности

Главные авторы:	Febin Antony, Arbind Dubey, Pamela Skrabek, Lung Fung Tsang, Pascal Lambert, Bohdan Bybel, Naseer Ahmed
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2024-01-01
Серии:	Current Oncology
Предметы:	lymphomas hypofractionation radiotherapy
Online-ссылка:	https://www.mdpi.com/1718-7729/31/1/25
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!